Mitral Valve

The heart's mitral valve is the site of the most surgical valve repairs and valve replacements. After the resounding success of transcatheter aortic valve replacement (TAVR), which now makes up more than 50% of aortic valve replacements, there is wide expectation transcatheter mitral replacements will follow in the next few year. Currently, the most common transcatheter mitral procedure is transcatheter edge-to-edge (TEER) , using the MitraClip or Pascal clip devices. These devices are also being used for transcatheter tricuspid valve repair (TTVR). Other transcatheter mitral repair systems are in trials for minimally invasive annuloplasty and chordae tendineae repair. 

Video of Makoto Hashimoto, MD, PhD, professor and director of robotic cardiac surgery at Florida International University, Baptist Health, who presented a study on robotic surgery outcomes and costs at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. While the costs of these minimally invasive robotic procedures is higher that traditional surgical procedures, he said costs overall can be reduced in terms of faster patient recovery, shorter length of stays.

Upfront costs of robotic heart surgery are high—but it may be a smart investment

Makoto Hashimoto, MD, PhD, said robotic procedures are associated with a faster recovery time and many other potential benefits.

PHOTO GALLERY: Cardiac surgery technologies at the AATS 106th Annual Meeting

A wide variety of technologies, including robotic systems, heart valves, stent grafts, retractors and annuloplasty rings, were on display in Chicago.

Mosaic Neo mitral valve from Medtronic

FDA approves next-gen mitral valve from Medtronic

The Mosaic Neo mitral bioprosthesis can be implanted through sternotomy, minimally invasive cardiac surgery or robotic access. 

Surgeons Operating On Patient

When bioprosthetic mitral valves fail: Redo surgery bests transcatheter treatment after 5 years

Short-term outcomes were comparable, but long-term data revealed a significant difference in all-cause mortality.

robot reviewing heart data

AI-powered EHR alerts make a world of difference for cardiologists, heart patients

AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.

Philips has secured U.S. Food and Drug Administration (FDA) clearance for EchoNavigator R5.0 with DeviceGuide, the company’s artificial intelligence (AI)-enabled software for mitral transcatheter edge-to-edge repair (M-TEER).

FDA clears new AI software for mitral valve repair

Philips worked closely with Edwards Lifesciences to develop the new software.

Valcare Medical’s Amend Transseptal System for mitral regurgitation

Interventional cardiologists implant new-look heart device for first time in US

The Amend device from Valcare Medical has a closed ring shape similar to the annuloplasty rings used to treat MR during open-heart surgeries. These early patients will be followed for a total of five years.

HighLife Transcatheter Mitral Valve Replacement (TMVR) System

TMVR device with valve-in-ring design gains key approval

HighLife's new-look TMVR technology was designed to treat a wide range of patients. The two-part implant process includes a ring and a valve that centers itself inside that ring.